These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16728216)

  • 21. The impact of circulating total homocysteine levels on long-term cardiovascular mortality in patients with acute coronary syndromes.
    Foussas SG; Zairis MN; Makrygiannis SS; Manousakis SJ; Patsourakos NG; Adamopoulou EN; Beldekos DJ; Melidonis AI; Handanis SM; Manolis AJ; Hatzisavvas JJ; Argyrakis SK
    Int J Cardiol; 2008 Mar; 124(3):312-8. PubMed ID: 17433477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose normalization and outcomes in patients with acute myocardial infarction.
    Kosiborod M; Inzucchi SE; Krumholz HM; Masoudi FA; Goyal A; Xiao L; Jones PG; Fiske S; Spertus JA
    Arch Intern Med; 2009 Mar; 169(5):438-46. PubMed ID: 19273773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between blood glucose on admission and prognosis in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Gasior M; Stasik-Pres G; Pres D; Lech P; Gierlotka M; Lekston A; Hawranek M; Tajstra M; Kalarus Z; Poloński L
    Kardiol Pol; 2007 Sep; 65(9):1031-8; discussion 1039-40. PubMed ID: 17975750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study).
    Pinto DS; Kirtane AJ; Pride YB; Murphy SA; Sabatine MS; Cannon CP; Gibson CM;
    Am J Cardiol; 2008 Feb; 101(3):303-7. PubMed ID: 18237589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
    Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P
    Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes.
    O'Donoghue M; de Lemos JA; Morrow DA; Murphy SA; Buros JL; Cannon CP; Sabatine MS
    Circulation; 2006 Aug; 114(6):550-7. PubMed ID: 16880323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of admission blood glucose on outcomes of nondiabetic patients with acute ST-elevation myocardial infarction (from the German Acute Coronary Syndromes [ACOS] Registry).
    Naber CK; Mehta RH; Jünger C; Zeymer U; Wienbergen H; Sabin GV; Erbel R; Senges J; Gitt A
    Am J Cardiol; 2009 Mar; 103(5):583-7. PubMed ID: 19231316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women.
    Westerhout CM; Lauer MS; James S; Fu Y; Wallentin L; Armstrong PW;
    Eur Heart J; 2007 Sep; 28(17):2064-9. PubMed ID: 17600040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
    Windhausen F; Hirsch A; Sanders GT; Cornel J; Fischer J; van Straalen JP; Tijssen JG; Verheugt FW; de Winter RJ;
    Am Heart J; 2007 Apr; 153(4):485-92. PubMed ID: 17383283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy.
    Dryja T; Kornacewicz-Jach Z; Goracy J; Przybycień K; Jodko L; Skowronek A; Kurowski M; Zinka E
    Kardiol Pol; 2006 Jun; 64(6):591-9; discussion 600-1. PubMed ID: 16810577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry.
    Kalińczuk Ł; Przyłuski J; Karcz M; Petryka J; Kaczmarska E; Bekta P; Kepka C; Kruk M; Pregowski J; Kadziela J; Deptuch T; Skwarek M; Cedro K; Ciszewski M; Debski A; Ciszewski A; Chmielak Z; Demkow M; Witkowski A; Ruzyłło W
    Kardiol Pol; 2007 Jan; 65(1):1-10; discussion 11-2. PubMed ID: 17295155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.
    de Lemos JA; Morrow DA; Blazing MA; Jarolim P; Wiviott SD; Sabatine MS; Califf RM; Braunwald E
    J Am Coll Cardiol; 2007 Nov; 50(22):2117-24. PubMed ID: 18036447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events.
    Svensson AM; McGuire DK; Abrahamsson P; Dellborg M
    Eur Heart J; 2005 Jul; 26(13):1255-61. PubMed ID: 15821004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers.
    Westerhout CM; Fu Y; Lauer MS; James S; Armstrong PW; Al-Hattab E; Califf RM; Simoons ML; Wallentin L; Boersma E;
    J Am Coll Cardiol; 2006 Sep; 48(5):939-47. PubMed ID: 16949483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
    Tricoci P; Lokhnygina Y; Berdan LG; Steinhubl SR; Gulba DC; White HD; Kleiman NS; Aylward PE; Langer A; Califf RM; Ferguson JJ; Antman EM; Newby LK; Harrington RA; Goodman SG; Mahaffey KW
    Circulation; 2007 Dec; 116(23):2669-77. PubMed ID: 18025532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
    Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent cardiac troponin I elevation in stabilized patients after an episode of acute coronary syndrome predicts long-term mortality.
    Eggers KM; Lagerqvist B; Venge P; Wallentin L; Lindahl B
    Circulation; 2007 Oct; 116(17):1907-14. PubMed ID: 17909103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial.
    Brouwer MA; Kievit PC; Dieker HJ; Veen G; Karreman AJ; Verheugt FW
    Am Heart J; 2008 Jun; 155(6):1039-46. PubMed ID: 18513517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials).
    Brilakis ES; de Lemos JA; Cannon CP; Wiviott SD; Murphy SA; Morrow DA; Sabatine MS; Banerjee S; Blazing MA; Califf RM; Braunwald E
    Am J Cardiol; 2008 Sep; 102(5):552-8. PubMed ID: 18721511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.